Dr. Allison Beth Webber, MD

Dr. Webber practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Webber's NPI, 1538328588, was assigned on June 5, 2008. Dr. Webber graduated from Albert Einstein College of Medicine in 2002. Dr. Webber holds California license A109068.

Dr. Webber's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Webber's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Webber to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Webber practices. Vendor and product names are available with a free account.

Nephrology is Dr. Webber's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Webber is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Webber's licenses on file in 3 states: California, Nevada and New York.

Dmand AI lists fluid and electrolyte imbalances, hypercalcemia, kidney disease and parathyroid gland disorder among the conditions Dr. Webber treats.

CMS data shows 824 Medicare services from Dr. Webber across 8 procedure codes in 2024, for 307 Medicare patients. Medicare paid $65,481 for them.

CMS counts 307 Medicare patients who saw Dr. Webber in 2024. The largest group is under 65, with 151 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 5.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Webber's median patient age at 58, with 44% women.

In 2024, Dr. Webber wrote 1,605 Medicare Part D claims for 285 patients. 88% of them were for generic drugs. CMS names the drug for 1,401 of them, across 27 drugs with 11 or more claims each, at $132,248 in total drug cost. In 2023, CMS named 1,363 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Webber for performance year 2024, reported as part of a group. Dr. Webber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Webber as offering telehealth.

Dmand AI links 18 papers to Dr. Webber, published from 2011 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Graft Rejection and Immunosuppressive Agents. Dr. Webber has published most often in Transplantation. Dr. Webber's most frequent co-authors are Ryutaro Hirose, MD, Garrett Richard Roll, MD and Shareef Mohammed Syed, MD.

Dmand AI links Dr. Webber to 2 clinical trials.

CMS Open Payments shows 1 general payment to Dr. Webber from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $25. It also lists 4 research payments totaling $1,241 in 2017.

Dmand AI lists 1 award for Dr. Webber, most recently CMS Stage 1 EHR in 2013.

Dr. Webber graduated from Albert Einstein College of Medicine in 2002.

Dr. Webber is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.